Plain-English translation of NCT06981234 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a medication that works on kidney function in a specific way, to see if it can help protect the kidneys of people with type 1 diabetes. Researchers want to understand whether this medication changes how well the kidneys filter waste from the blood. You would take the medication for 10 weeks, then have a break, and the study would measure your kidney function at different points.
People with type 1 diabetes are at risk of kidney damage over time, which is a serious long-term complication. This trial is exploring whether this medication might offer a new way to slow or prevent that kidney damage by changing how the kidneys work.
You likely qualify if…
You likely don't qualify if…
You would visit the study site multiple times over about 5 months. During each study period, you would either take the medication twice daily for 10 weeks or take a placebo (inactive pill) for 10 weeks, with a 2-week break between periods. At the beginning and end of each 10-week period, you would have a kidney function test that involves a special dye injection and blood draws to measure how well your kidneys are filtering. You would not know which group you're in — both you and the study staff would be blinded to keep the results fair.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States